The American Journal of Medicine
Volume 123, Issue 7, Supplement , Pages S9-S15, July 2010

One Size Does Not Fit All: The Role of Vasodilating β-Blockers in Controlling Hypertension as a Means of Reducing Cardiovascular and Stroke Risk

  • Jan N. Basile, MD

      Affiliations

    • Corresponding Author InformationRequests for reprints should be addressed to Jan N. Basile, MD, Seinsheimer Cardiovascular Health Program, College of Medicine, Medical University of South Carolina, 171 Ashley Avenue, Charleston, South Carolina 29425-0950

Seinsheimer Cardiovascular Health Program, College of Medicine, Medical University of South Carolina and Ralph H. Johnson VA Medical Center, Charleston, South Carolina, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Statement of author disclosure: Please see the Author Disclosures section at the end of this article.

 Dr. Basile is supported by the National Heart, Lung, and Blood Institute (NHLBI) through funding for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial and the Systolic Blood Pressure Intervention Trial (SPRINT).

PII: S0002-9343(10)00339-6

doi:10.1016/j.amjmed.2010.04.013

The American Journal of Medicine
Volume 123, Issue 7, Supplement , Pages S9-S15, July 2010

Article Tools

* Image Usage & Resolution